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Back and Forth from Basic Science to Clinical Translation 
 
Dear Editor, I enjoyed reading the interesting mini-review “Perioperative cardioprotection: back to bedside” 
by Lionetti and Barile 1. The authors have done an excellent job in summarizing the most salient aspects of 
this relevant and timely topic: how to prevent perioperative myocardial injury (MI) in cardiac and noncardiac 
surgery. The incidence of perioperative MI seems to be quite higher in cardiac surgery. Therefore, the 
majority of experts focus on this issue. However, given the huge number of surgical interventions also 
noncardiac surgery deserves to be considered. The authors should be commended for the effort they have 
made in considering these critical aspects in a balanced and precise way. Here I would like to underline the 
point of view of the basic researcher, who is trying to understand how the benefits observed in the laboratory 
can be translated into the clinical scenario. As pointed out by Lionetti and Barile, the researchers focused on 
studying cardiomyocytes mainly, however we understood that it is necessary to consider a plethora of cells 
(cardiac and non-cardiac) 2. Furthermore, not only cell death from necrosis matters: under stress and 
hypoxygenation cardiac cells can die with different mechanisms 3. Moreover, a neglected aspect is coronary 
microvascular dysfunction (CMD), which can also be involved in non-cardiac surgery in subjects with co-
morbidities and apparent normal coronary perfusion under basal conditions. Even in the absence of 
appreciable atherosclerosis, a fairly severe CMD can produce alterations in the myocardial oxygen balance, 
particularly during stress 4, such as during surgery. Last but not least, there is an urgent need to standardize 
cardioprotective procedures in laboratories and hospital wards 5. Basic research on micro-vesicles (released 
by circulating cells and by all types of cells present in the heart tissue), epigenomic and genomic aspects, as 
underlined by Lionetti and Barile, will be the tools that will allow a huge step forward in precision medicine 
and in perioperative care. Lionetti and Barile are among the pioneers who stressed the importance of these 
aspects and the paracrine effects of the factors released by cells. 
In conclusion, the Lionetti and Barile review suggests that we must identify new signaling pathways and 
therapeutic targets for cardioprotection, aimed at multiple signaling pathways and final effectors both inside 
and outside the cardiomyocyte, for an efficient multitarget therapy. We must consider the co-medications 
and co-morbidities that influence cardioprotection and the mechanisms of their interference in appropriate 
animal models. Only if basic and clinical researchers find new strategies and more effective approaches to 
cardioprotection and improves the rigor and reproducibility of experimental approaches, we can improve 
clinical translation and patient benefits. We need to go back and forth from the lab to the bedside to better 
understand the mechanisms of cardioprotection in order to counter stagnation in the clinical management 
of patients. 
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